HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McNeil, L. K. Articles by Evavold, B. D. Search for Related Content PubMed PubMed Citation Articles by McNeil, L. K. Articles by Evavold, B. D.

TCR Reserve: A Novel Principle of CD4 T Cell Activation by Weak Ligands ¹

Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322

Some ligand-receptor systems have a receptor reserve where a maximal response can be achieved by occupation of a fraction of available receptors. An implication of a receptor reserve is the expansion of the number of ligands for response. To determine whether T cells follow receptor reserve, we have characterized the effect of reducing TCR levels on CD4 T cell responses elicited by altered peptide ligands that vary in potency. Agonist peptide is unaffected by a 90% reduction in TCR level while proliferation to weak agonists is significantly inhibited when TCR expression is reduced by 40%. Thymocyte-negative selection similarly demonstrates a differential requirement of TCR for response to agonist, weak agonist, and partial agonist. Therefore, our data demonstrate receptor reserve as a novel principle of T cell activation in which excess TCRs expand the antigenic repertoire to include less potent ligands.

Related articles in The JI:

IN THIS ISSUE

The JI 2003 170: 1129-1130. [Full Text]  

This article has been cited by other articles:

				H. A. Wasserman, C. D. Beal, Y. Zhang, N. Jiang, C. Zhu, and B. D. Evavold MHC Variant Peptide-Mediated Anergy of Encephalitogenic T Cells Requires SHP-1 J. Immunol., November 15, 2008; 181(10): 6843 - 6849. [Abstract] [Full Text] [PDF]

				D. S. Jones, P. Reichardt, M. L. Ford, L. J. Edwards, and B. D. Evavold TCR Antagonism by Peptide Requires High TCR Expression J. Immunol., August 1, 2008; 181(3): 1760 - 1766. [Abstract] [Full Text] [PDF]

				H. A. Wasserman and B. D. Evavold Induction of Anergy by Antibody Blockade of TCR in Myelin Oligodendrocyte Glycoprotein-Specific Cells J. Immunol., June 1, 2008; 180(11): 7259 - 7264. [Abstract] [Full Text] [PDF]

				D. V. Serreze, C. M. Choisy-Rossi, A. E. Grier, T. M. Holl, H. D. Chapman, J. R. Gahagan, M. A. Osborne, W. Zhang, B. L. King, A. Brown, et al. Through Regulation of TCR Expression Levels, an Idd7 Region Gene(s) Interactively Contributes to the Impaired Thymic Deletion of Autoreactive Diabetogenic CD8+ T Cells in Nonobese Diabetic Mice J. Immunol., March 1, 2008; 180(5): 3250 - 3259. [Abstract] [Full Text] [PDF]

				T. K. Starr, M. A. Daniels, M. M. Lucido, S. C. Jameson, and K. A. Hogquist Thymocyte Sensitivity and Supramolecular Activation Cluster Formation Are Developmentally Regulated: A Partial Role for Sialylation J. Immunol., November 1, 2003; 171(9): 4512 - 4520. [Abstract] [Full Text] [PDF]